10′-Desmethoxystreptonigrin (CAS 136803-89-9)

10′-Desmethoxystreptonigrin, an analog of Streptonigrin, exhibits broad-spectrum antibacterial properties. The enhanced efficacy of this compound in inhibiting farnesylation of the RAS oncogene p21 protein suggests a potency that is threefold greater than its parent compound, Streptonigrin. The inhibition of farnesylation, a post-translational modification involving the attachment of a farnesyl group to the RAS protein, is significant because it interferes with the proper localization and function of RAS within the cell. By targeting this process, 10′-Desmethoxystreptonigrin disrupts a critical pathway used by bacteria to regulate various cellular processes, including growth and survival. This specific action makes it useful in the study of bacterial resistance mechanisms and the development of novel antibacterial strategies. Its role in protein modifications and its implications in bacterial pathogenicity and survival, provides insights that could lead to the development of targeted antibacterial agents.